The Ministry of Health of the Russian Federation in accordance with Article 32 of the Federal Law of 12.04.2010 No. 61-FZ "On the circulation of medicinal products" decided to abolish state registration and exclude from the state register of medicinal products for medical use of the medicinal product (registration certificate P N013547 / 01 from 09/09/2011 issuedAstraZeneca UK Limited, UK):
Acolat® (trade name of the medicinal product)
Zafirlukast (international non-proprietary or grouping or chemical name)
film-coated tablets, 20 mg (dosage form, dosage)
AstraZeneca UK Limited, United Kingdom Silk Road Business Park, Macclesfield, Cheshire, SK10 2NA, United Kingdom (name and address of the location of the manufacturer of the medicinal product)
on the basis of an application by the authorized legal entity LLC "AstraZeneca Pharmaceuticals" to cancel the state registration of the medicinal product.